Daily Token Analysis: Injective (INJ)



Market Performance and Analysis:

According to the latest data as of June 16, 2026, INJ experienced a deep correction earlier but was driven by multiple major positive fundamentals, resulting in a strong V-shaped rebound.

Price Dynamics: Currently trading strongly around $5.63, with a single-day increase of over 11.85%, and intraday highs reaching $5.74, demonstrating excellent support from institutional and retail buying.

Technical Perspective: Successfully reversed the previous downtrend, with the daily chart strongly testing the 50-day moving average resistance. The short-term bullish target is set towards the key previous high range of $6.30–$7.00; support levels have moved up to $4.92–$5.15. The RSI indicator has rebounded strongly from oversold territory, with bullish momentum accelerating.

Major Positive News:

Regulatory Funds and Asian Expansion: The Thai Securities and Exchange Commission (SEC) officially approved Merkle Capital to launch Asia’s first regulated INJ investment fund, "M-INJ," on June 5. Following the US CFTC’s approval of INJ futures, this opens a new channel for institutional compliant capital.

Vulcan Mainnet Upgrade: On June 9, the official successfully launched a major upgrade to Vulcan, fully optimizing the native RWA module, reducing cross-chain transaction fees, and introducing enterprise-grade APIs, establishing its leading position as a finance-focused Layer-1.

Decentralized AI Capital Wave: Influenced by recent macro events of tightening regulation on centralized AI in the US, a large amount of capital has fled and flowed into the Web3 AI sector. INJ, with its AI intelligent trading agent ecosystem, has become a core beneficiary of this sector rotation.

Disclaimer: For reference only, not investment advice.

#Injective #INJ $INJ
INJ-1.37%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned